top of page
LATEST NEWS
Professor John Campbell PhD FRSB shares insights into how treatment resistance in solid tumours can be overcome
We spoke to Professor John Campbell PhD FRSB, a member of our Scientific Advisory Board, to discuss a key question in oncology: How can treatment resistance in solid tumours be overcome?
21 minutes ago
Dr. Mark A. Exley shares what excites him most about joining LIfT as Chief Scientific Officer and the potential of LIfT’s technology
In this video, Dr. Mark A. Exley shares his background in biotech, what makes our neutrophil-based approach to cancer therapy so...
Apr 8
LIfT BioSciences Appoints Mark A. Exley as Chief Scientific Officer
Mark brings 30 years of experience in R&D spanning discovery to late-stage clinical development London, 7 April 2025 – LIfT BioSciences,...
Apr 7
bottom of page